XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.2
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2024
STOCKHOLDERS' EQUITY  
Schedule of common stock issued roll forward

 

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

2024

2023

Common stock:

Balance, beginning of quarter

186,361,476

174,532,043

183,606,708

171,656,030

Shares issued for stock options exercised

14,286

79,599

225,444

192,807

Agent growth incentive stock compensation

678,825

730,003

1,032,513

1,386,439

Agent equity stock compensation

2,892,648

2,558,438

5,082,570

4,664,807

Balance, end of quarter

189,947,235

177,900,083

189,947,235

177,900,083

Changes in the Company's stock compensation liability

Amount

Stock grant liability balance at December 31, 2022

$ 3,885

Stock grant liability increase year to date

3,832

Stock grants reclassified from liability to equity year to date

(2,717)

Balance, December 31, 2023

$ 5,000

Stock grant liability increase year to date

1,288

Stock grants reclassified from liability to equity year to date

(806)

Balance, June 30, 2024

$ 5,482

Schedule of shares repurchased

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

2024

2023

Treasury stock:

Balance, beginning of quarter

31,514,913

21,089,622

28,937,671

18,816,791

Repurchases of common stock

4,698,949

3,222,275

7,276,191

5,495,106

Balance, end of quarter

36,213,862

24,311,897

36,213,862

24,311,897